Αποτελέσματα Αναζήτησης
21 Μαρ 2022 · Introduction. Genetic carrier screening (GCS) means to identify DNA variants associated with specific genetic diseases and to provide information regarding the risk of transmitting them to the offspring, exploiting molecular tests in apparently healthy individuals.
- Table 1
417 DNA variants associated with 108 diseases: 23,453...
- Table 1
14 Φεβ 2020 · Here, we delineate a framework for a systems biology approach to infectious disease in three parts: discovery — the design, collection and analysis of omics data; representation — the...
1 Δεκ 2020 · By rationally designing drug carrier properties to interface with biological systems, researchers can overcome these barriers and improve drug delivery. This can be achieved by engineering drug carrier morphologies, surface chemistries, topographies, and installing dynamic responsive behaviors.
18 Απρ 2022 · Key problems associated with the clinical development of nanocarriers were discussed, comprising biological difficulties, large-scale fabrication, biocompatibility and protection, intellectual activity, authority rules and whole cost efficiency compared to current therapies.
8 Απρ 2020 · Live biotherapeutic products (LBPs) are defined as live organisms designed and developed to treat, cure, or prevent a disease or condition in humans 10. Notably, LBPs exclude vaccines,...
3 Μαΐ 2019 · A combination of active or passive drug carrier with an imaging or a diagnostic agent will generate ‘intelligent’ theranostics system able to monitor disease progression and evaluate therapeutic efficacy of the drug in real time.
14 Φεβ 2018 · Our results provide a more complete understanding of the role of asymptomatic carriers in transmission and highlight the importance of accurately incorporating carriers into models used to make decisions about disease control.
